期刊文献+

耐甲氧西林葡萄球菌对大环内酯类抗生素的耐药机制 被引量:5

Analysis of mechanisms of resistance of methicillin-resistant staphylococcus to macrolides
下载PDF
导出
摘要 目的 研究耐甲氧西林葡萄球菌(MRS)对大环内酯类(M)-林可酰胺类(L)-链阳菌素类(S)抗生素(MLS)的耐药机制,以指导临床用药。方法 采用K-B扩散法测定90株MRS临床分离株的MLS六种代表药物(红霉素、阿齐霉素、麦迪霉素、乙酰螺旋霉素,克林霉素和奎奴普丁/达福普丁)的药敏试验,分析其耐药表型,推测其耐药机制。结果 ①MRS对MLS有5种药敏表型,最主要的表型为ML耐药/S敏感(71.11%);MRSA和MRCNS的药敏表型分布不一样,未见奎奴普丁/达福普丁(QD)耐药。②MRSA有两种靶位改变所致的耐药表型。分别为11.1%和71.1%,另有两种机制不明表型,分别为6.7%和11.1%;未发现外排系统所致耐药表型。③MRCNS也有两种靶位改变所致的耐药表型分别为8.9%和71.1%;存在外排系统所致的耐药表型,为13.3%。结论 MRS均主要为靶位改变所致的耐药,MRSA存在两种不明机制耐药,MRCNS存在外排系统所致的耐药。 Objective To study resistance mechanisms of methicillin-resistant staphylococcus (MRS) to macrolides (M), lincosamides (L) and streptogramins (S) (MLS). Method To detect the susceptibility of 90 MRS strains with K-B diffusion test, analyze the resistant rates and phenotypes, speculating upon theirs resistance mechanisms. Results ①There were five resistant phenotypes of MRS to MLS, the main phenotypes was ML resistant/S susceptibility (71.11%), the phenotypes of MRSA, MRCNS were difference, no phenotype of QD resistant.②There are two kinds of phenotypes caused by target changing in MRSA, 11.1% and 71.1%, respectively, and there are two kinds phenotypes which caused by unclear reason, 6.7% and 11.1%, respectively, and no phenotypes caused by outer-pumps. ③There are two kinds of phenotypes caused by target changing in MRSCN, 8.9% and 71.1%, respectively, and there is a phenotype which caused by outer-pumps, 13.3%. Conclusions The resistant mechanisms of MRS to MLS are caused by target changing, there are two kinds phenotypes which caused by unclear reason in MRSA, and a phenotype which caused by outer-pumps in MRSCN. streptogramins
出处 《世界感染杂志》 2006年第2期140-141,共2页 World Journal of Infection
关键词 葡萄球菌 大环内酯类 林可酰胺类 链阳菌素类 甲氧西林 staphylococcus methicillin macrolides lincosamides
  • 相关文献

参考文献4

二级参考文献14

  • 1任文贵,邹云,王东,闫兴辉,张晓兵,娄俊.耐甲氧西林金黄色葡萄球菌对万古霉素敏感性的监测[J].中华医院感染学杂志,2004,14(8):924-925. 被引量:25
  • 2陆亚华,时庭文,陈虹,王玉玉,黄支密.肠球菌属产酶耐药基因研究[J].中华医院感染学杂志,2004,14(9):972-974. 被引量:6
  • 3National committee for clinical laboratory standards. Performance Standards for Antimicrobial Disk Susceptibility Tests [S]. M100-S12, NCCLS, 2002: 1-133.
  • 4Auckenthaler R, Courvalin P, Feger C, et al. In vitro activity of quinupristin/dalfopristin in comparision with five antibiotics against worldwide clinical isolates of staphylococci[J]. Clin Microbiol Infect, 2000, 6(11): 608-611.
  • 5Roberts MC, Sutcliffe J, Courvalin P, et al. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants[J]. Antimicrob Agent Chemother, 1999,43(12):2823-2830.
  • 6www. ncbi. nlm. nih. gov/nucloeotide. AF299292.
  • 7Giovanetti E, Magi G, Brenciani A, et al. Conjugative transfer of the erm (A) gene from erythromycin-resistant Streptococcus pyogenes to macrolide-susceptible S. pyogotes, Enterococcus faecalis and Listeria innocua[J]. J Antimicrob Chemother, 2002,50(2):249-252.
  • 8陈代杰.抗菌生物与细菌耐药性[M].上海:华东理工大学出版社,2001.90-111.
  • 9王明贵.细菌对大环内酯类抗生素耐药机制的研究进展[J].国外医药(抗生素分册),2000,21(1):13-15. 被引量:37
  • 10明德松.湖北地区2234株葡萄球菌对10种类型抗生素耐药性分析[J].中国医院药学杂志,2001,21(6):380-381. 被引量:1

共引文献58

同被引文献116

引证文献5

二级引证文献103

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部